GLP-one agonists mimic how a hormone named glucagon-like peptide one works in the human body. When blood sugar starts to rise right after someone eats, these medicines trigger the body to produce a lot more insulin. The additional insulin allows lower blood sugar. Dr. Camilleri and co-authors